At a glance
- Originator Nonindustrial source
- Class Antidepressants
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Alpha 2 adrenergic receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 02 Feb 2001 No-Development-Reported for Depression in Australia (Unknown route)
- 14 Aug 1996 Preclinical development for Depression in Australia (Unknown route)